Aller au contenu

Arthritis Consumer Experts & JointHealth™ Programs

@acejointhealth.bsky.social did:plc:ppp37mn2z5srv4cq6fouucqr

JointHealth™ — Your science-based source for easy-to-read arthritis info on treatments, research, and health policy. Visit us at www.jointhealth.org Follow us on Facebook: facebook.com/ACEJointHealth

Sur Bluesky depuis le

Abonnés
140
Abonnements
61
Posts
293
Jours dans les classements
0

Résumé

Arthritis Consumer Experts & JointHealth™ Programs (@acejointhealth.bsky.social) est sur Bluesky depuis le 19 novembre 2024. Le compte a 140 abonnés, suit 61 comptes et a publié 293 posts.

Présence dans les classements

Les meilleurs jours où les posts de ce compte sont entrés dans le top quotidien de Debya.

Ce compte n’est encore apparu dans aucun classement quotidien.

Posts aimés récemment

J’aime publics du réseau Bluesky.

  • ACR Journals@acr-journals.bsky.social

    Case-cohort study within ELSA-Brasil (N=585) investigated coronary artery calcium (CAC) prevalence in rheumatoid arthritis. RA was not associated with CAC prevalence or incidence, but was associated with greater CAC progression over a 4-year period Arthritis Care & Research doi.org/10.1002/acr....

    Voir le post
  • ACR Journals@acr-journals.bsky.social

    Can rheumatoid arthritis remission be predicted using routine baseline data? In 28,900 treatment courses across 11 registries, an externally validated machine learning model showed good rule-out performance but limited gain over logistic regression Arthritis & Rheumatology doi.org/10.1002/art....

    Voir le post
  • A Chronic Voice@achronicvoice.com

    "Sometimes I pushed myself to do [the #work ] anyway..just to keep the peace & wound up making myself sick or nearly passing out." (Realities of Trying to Maintain #Employment with a #Disability): buff.ly/PLvijUc by @2HeartCore4U.bsky.social #ChronicIllness #career #workplace #accommodations

    Voir le post
  • ACR Journals@acr-journals.bsky.social

    Among 66 patients with Still's disease receiving first-line IL-1 inhibitor therapy, IL-18 levels, particularly at 3 months after IL-1i initiation, could predict long-term disease activity, risk of MAS, & chronic-persistent disease trajectory Arthritis & Rheumatology doi.org/10.1002/art.... #Medsky

    Voir le post
  • ACR Journals@acr-journals.bsky.social

    Comparing effects of JAKi on endothelial cell dysfunction & apoptosis showed that despite JAKi protective effects, thrombotic risk factors triggered by TNF & IL-17A persist after treatment with most JAKi. Peficitinib & fedratinib inhibited endothelial cell viability doi.org/10.1002/acr2... #Medsky

    Voir le post

Connectez-vous pour en voir plus

Comptes bloqués

Sur Bluesky, les blocages sont publics.

Ce compte ne bloque personne.